Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-associated Enteropathy”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Very early researchStudy completedNCT01313910
What this trial is testing

CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements

Who this might be right for
HIV
University of California, Davis 8
Testing effectiveness (Phase 2)Study completedNCT00324415
What this trial is testing

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

Who this might be right for
Anal Cancer
AIDS Malignancy Consortium 45
Early research (Phase 1)Study completedNCT01158274
What this trial is testing

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more
National Cancer Institute (NCI) 30
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Not applicableStudy completedNCT00188292
What this trial is testing

Screening for HIV-Associated Anal Cancer

Who this might be right for
HIV InfectionsAnal CancerAnal Dysplasia+1 more
University Health Network, Toronto 401
Not applicableStudy completedNCT05510908
What this trial is testing

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Who this might be right for
HIV-Associated Malignant NeoplasmHIV InfectionsCancer+5 more
AIDS Malignancy Consortium 460
Not applicableUnknownNCT03713502
What this trial is testing

Enteropathy and Diabetes in HIV Patients

Who this might be right for
DiabetesEnvironmental EnteropathyHIV
National Institute for Medical Research, Tanzania 1,947
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Testing effectiveness (Phase 2)WithdrawnNCT07090174
What this trial is testing

CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Who this might be right for
HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal Cancer+2 more
University of California, San Diego
Not applicableStudy completedNCT00816842
What this trial is testing

Plasma Citrulline Concentration in Tropical Enteropathy

Who this might be right for
Malabsorption SyndromesGranulomatous EnteritisEnteritis+2 more
Azienda Ospedaliero-Universitaria di Parma
Not applicableStudy completedNCT01828593
What this trial is testing

Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy

Who this might be right for
HIV-associated Enteropathy
Entera Health, Inc 103
Large-scale testing (Phase 3)Study completedNCT01374490
What this trial is testing

Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea

Who this might be right for
HIV EnteropathyDiarrhea With HIV
Bausch Health Americas, Inc. 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04929028
What this trial is testing

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Who this might be right for
AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell Carcinoma+7 more
National Cancer Institute (NCI) 40